Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Celsius Therapeutics
Agios’ cellular metabolism expertise first delivered cancer drugs but sees greater opportunity in genetically defined diseases. CEO Jackie Fouse talked to Scrip about the business strategy.
Although SRF813 isn’t likely to reach the clinic until 2021, GSK likes cell therapy’s monotherapy and combination potential. Lilly bids $880m to acquire neurodegenerative cell therapy firm Prevail.
New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.
The New York biotech announces option deals with two universities, asset license from CBM BioPharma. Bayer inks research collaborations with Japan’s RiKen and with a pair of Boston research hospitals.
- Digital Health
Drug Discovery Tools
- Drug Discovery Tools